Advertisement

Ads Placeholder
Loading...

Satellos Bioscience Inc.

MSCLF•PNK
Healthcare
Biotechnology
$6.25
$0.66(11.81%)
U.S. Market opens in 5h 11m

Satellos Bioscience Inc. (MSCLF) Stock Overview

Explore Satellos Bioscience Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap96.6M
P/E Ratio-0.31
EPS (TTM)$2.57
ROE-0.70%
Fundamental Analysis

AI Price Forecasts

1 Month$6.80
3 Months$6.86
1 Year Target$7.19

MSCLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Satellos Bioscience Inc. (MSCLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.31 and a market capitalization of 96.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
11.81%
5-Day Change
3.48%
1-Month Change
-46.35%
3-Month Change
-14.97%
6-Month Change
-10.07%
Year-to-Date (YTD) Change
0.81%
1-Year Change
19.73%
3-Year Change
33.55%
5-Year Change
-66.61%
All-Time (Max) Change
-85.03%

Contact Information

https://satellos.com
647 660 1780
65 Front Street East, Toronto, ON, M5E 1B5

Company Facts

140 Employees
IPO DateAug 3, 2012
CountryCA
Actively Trading

Frequently Asked Questions